Anterior shoulder instability is a common problem, with shoulder dislocations occurring at a rate of 23.9 per 100,000 person-years.^[@bibr31-2325967120926465]^ The most common surgical techniques used to address anterior shoulder instability consist of arthroscopic Bankart repair, open Bankart repair, and the Latarjet procedure. The treatment of shoulder instability depends on many factors including patient demographics, number of dislocations, and associated injuries to the glenoid and/or humerus. Over the past 2 decades, there has been a significant trend toward arthroscopic stabilization, with arthroscopic surgery accounting for nearly 90% of procedures from a 2009 national database.^[@bibr23-2325967120926465],[@bibr32-2325967120926465]^

Several studies have previously compared the costs of arthroscopic and open techniques of anterior shoulder stabilization.^[@bibr1-2325967120926465],[@bibr21-2325967120926465],[@bibr26-2325967120926465],[@bibr30-2325967120926465]^ Min et al^[@bibr21-2325967120926465]^ found arthroscopic Bankart repair was a more cost-effective method of treating primary shoulder instability than was the Latarjet procedure. This contrasts with the findings of Uffmann et al,^[@bibr29-2325967120926465]^ who found that Bankart repair was more costly because of higher implant costs. However, sufficient data were not available to draw conclusions regarding specific patient-, surgery-, and center-derived variables at a national level within these studies. As bundled payments become more of the norm in medicine, having the ability to identify specific factors associated with the increased cost of these procedures may help physicians and payers decrease the overall monetary burden on society. Kuye et al^[@bibr15-2325967120926465]^ noted a lack of high-quality economic analyses regarding shoulder injuries, despite their high prevalence in the general population.

In the current study, the State Ambulatory Surgery and Services Databases (SASD) were utilized to examine patient and surgical data relating to the cost of anterior shoulder stabilization. We hypothesized that increased costs would be associated with low-volume surgeons and surgical facilities, hospital-owned facilities, open surgical techniques, and patients with at least 1 comorbidity. We also sought to identify additional variables that may be associated with increased costs for anterior shoulder stabilization procedures. Our objective was to show where cost savings can be achieved, particularly considering increasing trends toward bundled health care payments.

Methods {#section1-2325967120926465}
=======

Data Source {#section2-2325967120926465}
-----------

This study utilized the 2014 SASD, a part of the Healthcare Cost and Utilization Project (HCUP). The HCUP is a well-validated data source for a number of medical procedures.^[@bibr2-2325967120926465],[@bibr4-2325967120926465],[@bibr8-2325967120926465],[@bibr11-2325967120926465],[@bibr28-2325967120926465]^ The SASD consist of encounter-level data for outpatient surgical procedures performed in both hospital-owned and freestanding ambulatory surgery centers. The databases collect \>200 data points on patient demographics, surgical variables, and procedure details for every encounter. This study utilized databases from the states of Florida, Kentucky, Iowa, Maryland, Nevada, and New York. These states were selected in an effort to provide a geographically representative sample. This geographic subset has been previously validated in studies assessing cost data in orthopaedic procedures.^[@bibr3-2325967120926465],[@bibr17-2325967120926465]^

Data Collection {#section3-2325967120926465}
---------------

All cases with Current Procedural Terminology (CPT) codes 23455 (capsulorrhaphy, anterior, with labral repair), 23462 (capsulorrhaphy, anterior, any type; with coracoid process transfer), and 29806 (arthroscopy, shoulder, surgical; capsulorrhaphy) were selected. Unique physician and surgical facility identifiers were used to calculate the caseload. Any cases that also included CPT codes 29827 (arthroscopy, shoulder, with rotator cuff repair) or 29826 (arthroscopy, shoulder, subacromial decompression) were excluded, as were cases with missing or incomplete charge data.

Total charges in 2014 US dollars were used as a primary outcome variable in this study to approximate the cost of surgery, as previous HCUP database studies have demonstrated total charges as a useful proxy measure for estimating costs.^[@bibr3-2325967120926465],[@bibr16-2325967120926465],[@bibr17-2325967120926465]^ Moreover, utilizing total charge data allows for the analysis of trends that may be identified in how surgery centers bill for different demographic groups and for different surgical methods. These trends may show areas where there is a potential for cost savings. This approach has been validated in several recent publications.^[@bibr3-2325967120926465],[@bibr16-2325967120926465],[@bibr17-2325967120926465]^

Statistical Analysis {#section4-2325967120926465}
--------------------

A number of patient demographic and surgical variables were tested for significance. Demographic variables included patient age, sex, race, presence of at least 1 medical comorbidity, type of insurance, and income quartile of the patient's ZIP code. Income quartiles were based off of the median household income of residents in the patient\'s ZIP code. The first quartile was from \$1 to \$39,999, the second quartile was from \$40,000 to \$50,999, the third quartile was from \$51,000 to \$65,999, and the fourth quartile was \$66,000 or greater. Surgical variables included type of anesthesia, postoperative admission to the hospital, surgery center ownership (hospital vs privately owned), physician volume, and facility volume. These variables were first tested on a univariate basis using single linear regression, independent-samples *t* test, and 1-way analysis of variance as applicable. Significant variables based on univariate analysis (*P* \< .05) were then included in the multiple linear regression to model the cost of individual anterior stabilization techniques while controlling for all significant factors. Additionally, a comparison of operative times between low- and high-volume surgical facilities was performed. All *P* values \<.05 were considered significant (SPSS Statistics Version 25.0; IBM Corp).

Both surgeon and facility volume were divided into high- and low-volume categories. Receiver operating characteristic analysis was performed to determine the cutoffs. As has been previously described, cutoff values were identified by finding the maximum of the sum of sensitivity and specificity.^[@bibr12-2325967120926465]^ For arthroscopic Bankart repair, receiver operating characteristic analysis resulted in a physician volume cutoff of 11 cases per year and a facility volume cutoff of 39 cases per year. For both open Bankart repair and the Latarjet procedure, the physician volume cutoff was 5 cases, and the facility volume cutoff was 8 cases.

Results {#section5-2325967120926465}
=======

After exclusions, there were 6498 arthroscopic Bankart cases, 318 open Bankart cases, and 287 Latarjet cases. The mean costs of surgery were \$18,842 ± \$12,746 for the arthroscopic Bankart group, \$20,690 ± \$15,540 for the open Bankart group, and \$20,275 ± \$13,800 for the Latarjet group. The difference between arthroscopic and open Bankart repair was significant (*P* = .013), but there was no significant difference between arthroscopic Bankart repair and the Latarjet procedure (*P* = .063) or between open Bankart repair and the Latarjet procedure (*P* = .730).

Patient Demographic Variables {#section6-2325967120926465}
-----------------------------

Increasing patient age added cost for all 3 treatment methods ([Table 1](#table1-2325967120926465){ref-type="table"}). Each additional year of age added from \$72 (arthroscopic Bankart: *P* \< .001) to \$231 (Latarjet: *P* = .002). Patient race was also significant for arthroscopic Bankart repair, with Hispanic patients having 20% higher costs than non-Hispanic white patients (*P* \< .001) ([Table 2](#table2-2325967120926465){ref-type="table"}). This same trend was also present for the Latarjet procedure but only approached statistical significance (*P* = .084). Male patients had 12% higher costs than female patients in the arthroscopic Bankart group (*P* \< .001) ([Table 2](#table2-2325967120926465){ref-type="table"}). The presence of at least 1 comorbidity was a significant cost driver in all 3 groups ([Table 2](#table2-2325967120926465){ref-type="table"}). Patients with comorbidities had 15% higher costs in the arthroscopic Bankart group (*P* \< .001), 23% higher costs in the open Bankart group (*P* = .016), and 26% higher costs in the Latarjet group (*P* = .005). Patients with public insurance had higher costs than patients with private insurance in the arthroscopic Bankart group ([Table 3](#table3-2325967120926465){ref-type="table"}). Patients with Medicaid had 12% higher costs, and patients with Medicare had 26% higher costs (both *P* \< .001). Patients living in lower-income ZIP codes also had higher costs across all 3 treatment methods ([Table 3](#table3-2325967120926465){ref-type="table"}). Compared with patients in the highest-income ZIP codes, patients living in the lowest-income ZIP codes had 23% higher costs in the arthroscopic Bankart group (*P* \< .001), 6% higher costs in the open Bankart group (*P* = .009), and 41% higher costs in the Latarjet group (*P* = .002).

###### 

Univariate Analysis of Patient Age for Cost of 3 Procedures*^a^*

![](10.1177_2325967120926465-table1)

  Surgery Type           Constant (SE), \$   B Coefficient (SE), \$   *P* Value
  ---------------------- ------------------- ------------------------ ------------
  Arthroscopic Bankart   16,832 (378)        72 (12)                  **\<.001**
  Open Bankart           16,087 (2037)       156 (62)                 **.013**
  Latarjet               13,629 (2268)       231 (74)                 **.002**

*^a^*Bolded *P* values indicate statistically significant difference (*P* \< .05). B coefficient indicates added cost per year of increasing age. SE, standard error.

###### 

Univariate Analysis of Demographic Variables for Cost of 3 Procedures*^a^*

![](10.1177_2325967120926465-table2)

  Variable                Patients, %   Cost, Mean ± SD, \$   *P* Value
  ----------------------- ------------- --------------------- ------------
  Race                                                        
   Arthroscopic Bankart                                       **\<.001**
    White                 72.6          18,860 ± 12,398       
    Black                 9.6           19,415 ± 12,690       
    Hispanic              7.2           22,704 ± 13,367       
    Asian                 1.5           16,182 ± 8885         
    Native American       0.2           15,592 ± 13,284       
    Other                 8.8           18,738 ± 15,848       
   Open Bankart                                               .433
    White                 73.5          21,935 ± 15,719       
    Black                 9.2           20,044 ± 16,240       
    Hispanic              5.3           24,819 ± 22,138       
    Asian                 2.5           29,761 ± 27,613       
    Other                 9.5           18,350 ± 9932         
   Latarjet                                                   .084
    White                 71.6          19,839 ± 13,173       
    Black                 8.0           19,513 ± 13,188       
    Hispanic              5.1           31,224 ± 17,913       
    Asian                 1.1           20,478 ± 5273         
    Other                 14.2          22,479 ± 15,373       
  Sex                                                         
   Arthroscopic Bankart                                       **\<.001**
    Female                25.9          17,353 ± 12,518       
    Male                  74.1          19,362 ± 12,785       
   Open Bankart                                               .377
    Female                78.6          21,092 ± 15,789       
    Male                  21.4          19,210 ± 14,604       
   Latarjet                                                   .789
    Female                83.6          20,371 ± 13,500       
    Male                  16.4          19,782 ± 15,392       
  Comorbidities                                               
   Arthroscopic Bankart                                       **\<.001**
    None                  57.0          17,679 ± 12,160       
    At least 1            43.0          20,383 ± 13,330       
   Open Bankart                                               **.016**
    None                  66.7          19,206 ± 12,952       
    At least 1            33.3          23,658 ± 19,460       
   Latarjet                                                   **.005**
    None                  64.1          18,555 ± 12,058       
    At least 1            35.9          23,347 ± 16,072       

*^a^*Bolded *P* values indicate statistically significant difference (*P* \< .05).

###### 

Univariate Analysis of Economic Variables for Cost of 3 Procedures*^a^*

![](10.1177_2325967120926465-table3)

  Variable                                Patients, %   Cost, Mean ± SD, \$   *P*
  --------------------------------------- ------------- --------------------- ------------
  Insurance                                                                   
   Arthroscopic Bankart                                                       **\<.001**
    Medicare                              2.4           23,402 ± 16,434       
    Medicaid                              10.2          20,773 ± 13,135       
    Private insurance                     69.4          18,568 ± 11,758       
    Other                                 18.0          18,202 ± 15,180       
   Open Bankart                                                               .609
    Medicare                              3.1           26,763 ± 24,664       
    Medicaid                              17.3          20,797 ± 17,276       
    Private insurance                     65.4          20,646 ± 14,545       
    Other                                 14.2          19,413 ± 15,615       
   Latarjet                                                                   .295
    Medicare                              3.5           26,722 ± 16,192       
    Medicaid                              12.9          21,949 ± 15,138       
    Private insurance                     73.9          19,490 ± 12,930       
    Other                                 9.8           21,701 ± 17,078       
  Income quartile of patient's ZIP code                                       
   Arthroscopic Bankart                                                       **\<.001**
    1                                     17.1          20,799 ± 14,094       
    2                                     23.8          20,935 ± 14,511       
    3                                     24.3          18,168 ± 11,858       
    4                                     34.8          16,904 ± 10,914       
   Open Bankart                                                               **.009**
    1                                     16.2          19,117 ± 11,238       
    2                                     22.0          25,810 ± 23,129       
    3                                     26.8          21,490 ± 15,385       
    4                                     35.0          17,995 ± 10,018       
   Latarjet                                                                   **.002**
    1                                     22.3          25,927 ± 17,336       
    2                                     18.8          18,501 ± 10,740       
    3                                     22.7          18,755 ± 15,259       
    4                                     36.2          18,452 ± 9987         

*^a^*Bolded *P* values indicate statistically significant difference (*P* \< .05).

Surgical Variables {#section7-2325967120926465}
------------------

Several surgical variables were found to be cost drivers. Each additional minute in the OR added from \$71 (Latarjet: *P* \< .001) to \$98 (open Bankart: *P* \< .001) ([Table 4](#table4-2325967120926465){ref-type="table"}). Patients receiving regional anesthesia had higher costs than patients receiving general anesthesia alone, with 29% higher costs in the arthroscopic Bankart group (*P* \< .001) and 18% higher costs in the Latarjet group (*P* = .007) ([Table 5](#table5-2325967120926465){ref-type="table"}). Postoperative admission to the hospital was a large cost driver in the arthroscopic Bankart and Latarjet groups, adding \$15,765 and \$10,016, respectively (both *P* \< .001) ([Table 5](#table5-2325967120926465){ref-type="table"}). Privately owned surgery centers had lower costs across all 3 treatment methods ([Table 5](#table5-2325967120926465){ref-type="table"}). At privately owned facilities, costs were 18% lower for the arthroscopic Bankart group (*P* \< .001), 40% lower in the open Bankart group (*P* \< .001), and 45% lower in the Latarjet group (*P* \< .001). Across all 3 treatment methods, increased costs were found for low-volume physicians and low-volume surgical facilities ([Table 6](#table6-2325967120926465){ref-type="table"}). Low-volume physicians had 5% higher costs in the arthroscopic Bankart group (*P* = .04), 50% higher costs in the open Bankart group (*P* = .016), and 53% higher costs in the Latarjet group (*P* = .006). The same trends were true for low-volume facilities, which had 17% higher costs in the arthroscopic Bankart group (*P* \< .001), 28% higher costs in the open Bankart group (*P* = .015), and 26% higher costs in the Latarjet group (*P* = .024).

###### 

Univariate Analysis of Operative Time for Cost of 3 Procedures*^a^*

![](10.1177_2325967120926465-table4)

  Surgery Type           Constant (SE), \$   B Coefficient (SE), \$   *P* Value
  ---------------------- ------------------- ------------------------ ------------
  Arthroscopic Bankart   10,672 (528)        80 (5)                   **\<.001**
  Open Bankart           6624 (1946)         98 (14)                  **\<.001**
  Latarjet               5961 (2217)         71 (14)                  **\<.001**

*^a^*Bolded *P* values indicate statistically significant difference (*P* \< .05). B coefficient indicates added cost per minute of additional time.

###### 

Univariate Analysis of Surgical Variables for Cost of 3 Procedures*^a^*

![](10.1177_2325967120926465-table5)

  Variable                           Patients, %   Cost, Mean ± SD, \$   *P*
  ---------------------------------- ------------- --------------------- ------------
  Anesthesia                                                             
   Arthroscopic Bankart                                                  **\<.001**
    General anesthesia               55.1          15,399 ± 9998         
    Regional anesthesia              21.3          19,807 ± 9919         
    Other                            23.6          15,287 ± 10,501       
   Open Bankart                                                          .224
    General anesthesia               61.7          18,612 ± 12,293       
    Regional anesthesia              27.8          21,870 ± 7619         
    Other                            10.5          17,264 ± 4510         
   Latarjet                                                              **.007**
    General anesthesia               44.2          16,928 ± 10,202       
    Regional anesthesia              36.2          19,914 ± 8170         
    Other                            19.6          12,944 ± 8003         
  Postoperative hospital admission                                       
   Arthroscopic Bankart                                                  **\<.001**
    Not admitted                     98.0          18,514 ± 12,268       
    Admitted                         2.0           34,279 ± 21,724       
   Open Bankart                                                          .112
    Not admitted                     86.1          20,171 ± 15,331       
    Admitted                         13.9          24,188 ± 16,613       
   Latarjet                                                              **\<.001**
    Not admitted                     88.4          19,079 ± 12,634       
    Admitted                         11.6          29,095 ± 18,951       
  Surgery center ownership                                               
   Arthroscopic Bankart                                                  **\<.001**
    Hospital owned                   73.6          16,437 ± 9543         
    Privately owned                  26.4          13,493 ± 11,403       
   Open Bankart                                                          **\<.001**
    Hospital owned                   75.7          18,863 ± 10,886       
    Privately owned                  24.3          11,367 ± 4731         
   Latarjet                                                              **\<.001**
    Hospital owned                   86.2          17,800 ± 9618         
    Privately owned                  13.8          9780 ± 4799           

*^a^*Bolded *P* values indicate statistically significant difference (*P* \< .05).

###### 

Univariate Analysis of Physician and Surgical Facility Volume for Cost of 3 Procedures*^a^*

![](10.1177_2325967120926465-table6)

  Variable                    Cases, %   Cost, Mean ± SD, \$   *P*
  --------------------------- ---------- --------------------- ------------
  Physician volume                                             
   Arthroscopic Bankart                                        **.04**
    Low volume (\<11 cases)   53.5       22,014 ± 16,089       
    High volume (≥11 cases)   46.5       20,937 ± 12,643       
   Open Bankart                                                **.016**
    Low volume (\<5 cases)    72.5       24,394 ± 21,389       
    High volume (≥5 cases)    27.5       16,251 ± 9918         
   Latarjet                                                    **.006**
    Low volume (\<5 cases)    71.0       26,702 ± 18,962       
    High volume (≥5 cases)    29.0       17,488 ± 7646         
  Facility volume                                              
   Arthroscopic Bankart                                        **\<.001**
    Low volume (\<39 cases)   49.6       20,329 ± 14,439       
    High volume (≥39 cases)   50.4       17,382 ± 10,629       
   Open Bankart                                                **.015**
    Low volume (\<8 cases)    64.4       21,975 ± 17,913       
    High volume (≥8 cases)    35.6       17,208 ± 11,145       
   Latarjet                                                    **.024**
    Low volume (\<8 cases)    72.0       21,355 ± 16,396       
   High volume (≥8 cases)     28.0       16,999 ± 3856         

*^a^*Bolded *P* values indicate statistically significant difference (*P* \< .05).

Comparison of Operative Times {#section8-2325967120926465}
-----------------------------

Operative times were shorter at high- than low-volume facilities for the arthroscopic Bankart group, requiring 6 fewer minutes (*P* \< .001) ([Table 7](#table7-2325967120926465){ref-type="table"}). There was no significant difference between high- and low-volume groups for open Bankart repair or the Latarjet procedure. Both open Bankart repair and the Latarjet procedure required longer operative times when compared with arthroscopic Bankart repair (*P* \< .001).

###### 

Comparison of Operative Times for 3 Procedures*^a^*

![](10.1177_2325967120926465-table7)

  Surgery Type              Operative Time, min   95% CI          *P* Value (Within Group)   *P* Value (Across Groups)
  ------------------------- --------------------- --------------- -------------------------- ---------------------------
  Arthroscopic Bankart                                            **\<.001**                 **\<.001**
   Low-volume facilities    105.79                102.68-108.90                              
   High-volume facilities   99.60                 97.33-101.86                               
  Open Bankart                                                    .308                       
   Low-volume facilities    122.87                109.22-136.52                              
   High-volume facilities   132.75                119.73-145.77                              
  Latarjet                                                        .929                       
   Low-volume facilities    152.71                143.09-162.33                              
   High-volume facilities   153.55                136.26-170.83                              

*^a^*Bolded *P* values indicate statistically significant difference (*P* \< .05).

Multivariate Analysis of Cost Drivers {#section9-2325967120926465}
-------------------------------------

Using multiple linear regression, we identified several variables that affected the cost of each type of anterior instability repair procedure. For the arthroscopic Bankart group, time in the OR, postoperative admission to the hospital, income quartile of the patient's ZIP code, surgery center ownership, presence of a comorbidity, facility volume, sex, race, and type of anesthesia all affected cost ([Table 8](#table8-2325967120926465){ref-type="table"}). The largest cost driver of these was postoperative admission to the hospital, adding \$11,516 (*P* \< .001). Living in a ZIP code with a below-median income added \$2909 (*P* \< .001), and use of regional anesthesia added \$1898 (*P* = .025). Undergoing surgery at a high-volume facility decreased costs by \$2077 (*P* \< .001).

###### 

Multivariate Analysis of Cost Drivers for 3 Procedures*^a^*

![](10.1177_2325967120926465-table8)

                                         B (SE), \$      *P*          95% CI for B, \$
  -------------------------------------- --------------- ------------ --------------------
  Arthroscopic Bankart                                                
   Constant                              11,540 (721)    **\<.001**   10,125 to 12,954
   Operative time                        69 (5)          **\<.001**   60 to 78
   Postoperative admission to hospital   11,516 (1633)   **\<.001**   8313 to 14,719
   Lower-income ZIP code                 2909 (464)      **\<.001**   1999 to 3819
   Privately-owned surgery center        --3 (1)         **\<.001**   --4 to --1
   Presence of comorbidity               1982 (455)      **\<.001**   1089 to 2875
   High-volume facility                  --2077 (461)    **\<.001**   --2981 to --1173
   Female sex                            --1545 (513)    **.003**     --2551 to --540
   Hispanic race                         2493 (890)      **.005**     747 to 4239
   Regional anesthesia                   1898 (847)      **.025**     236 to 3559
  Open Bankart                                                        
   Constant                              4148 (2846)     .147         --1482 to 9777
   Operative time                        147 (20)        **\<.001**   108 to 187
   High-volume facility                  --6146 (2349)   **.010**     --10,791 to --1501
  Latarjet                                                            
   Constant                              4512 (4556)     .324         --4495 to 13,518
   Operative time                        96 (19)         **\<.001**   59 to 134
   Privately owned surgery center        --15 (4)        **\<.001**   --24 to --7
   High-volume facility                  --6015 (2240)   **.008**     --10,443 to --1587
   Postoperative admission to hospital   7028 (3038)     **.022**     1022 to 13,034
   Age                                   187 (90)        **.039**     9 to 365

*^a^*Bolded *P* values indicate statistically significant difference (*P* \< .05). B coefficient indicates added cost for each factor.

For the open Bankart group, operative time and facility volume both significantly affected costs ([Table 8](#table8-2325967120926465){ref-type="table"}). Each additional minute in the OR added \$147 (*P* \< .001), and undergoing surgery at a high-volume facility decreased costs by \$6146 (*P* = .010).

For the Latarjet group, operative time, surgery center ownership, facility volume, postoperative admission to the hospital, and patient age were significant cost drivers ([Table 8](#table8-2325967120926465){ref-type="table"}). As with the arthroscopic Bankart group, the largest cost driver was postoperative hospital admission, adding \$7028 (*P* = .022). Each additional minute in the OR added \$96 (*P* \< .001), and each year of age added \$187 (*P* = .039). Privately owned surgery centers and high-volume surgical facilities both provided cost savings. High-volume facilities decreased costs by \$6015 (*P* = .008).

Discussion {#section10-2325967120926465}
==========

This study used large geographically representative databases to determine the cost drivers of common anterior shoulder instability procedures in the United States. Previous studies have aimed to determine the least expensive or most cost-effective surgical method of addressing instability.^[@bibr1-2325967120926465],[@bibr21-2325967120926465],[@bibr26-2325967120926465],[@bibr29-2325967120926465],[@bibr30-2325967120926465]^ This study adds several findings to the previous literature about specific cost drivers within each procedure on a national level. We found that patient age, presence of comorbidities, income quartile of a patient's ZIP code, surgery center ownership, operative time, physician volume, and surgical facility volume were significant factors in determining the cost of all 3 surgical procedures assessed. Additionally, patient race, sex, insurance, type of anesthesia, and postoperative hospital admission affected costs in at least 1 type of treatment method.

Similarly, our analysis found that high-volume surgical facilities provided substantial cost savings to patients undergoing all 3 procedures. These savings ranged from \$2077 in the arthroscopic Bankart group to \$6146 in the open Bankart group. Facility volume has been previously investigated for several inpatient orthopaedic procedures; patients at high-volume facilities have lower mortality rates and shorter lengths of stay than have patients at low-volume facilities.^[@bibr7-2325967120926465],[@bibr9-2325967120926465],[@bibr24-2325967120926465]^ Additionally, patients undergoing anterior cruciate ligament reconstruction have been shown to have a higher risk of requiring revision anterior cruciate ligament reconstruction when surgery was performed at a low-volume facility.^[@bibr18-2325967120926465]^ It is possible that these high-volume facilities are able to provide both superior patient outcomes and lower costs because of greater experience of the physicians and support staff with the procedure. It should be noted that high-volume surgeons provided cost savings for all 3 treatment methods in the univariate analysis but did not have a significant effect in the multivariate regression. This may have been as a result of controlling for several surgeon-modifiable factors, such as anesthesia type and operative time. Cost savings may also be more prominent at the facility level because savings from multiple surgeons may aggregate.

In both univariate and multivariate analyses, privately owned surgery centers were able to deliver cost savings to patients undergoing arthroscopic Bankart repair and the Latarjet procedure. The univariate analysis showed that privately owned surgery centers delivered 18% lower costs for the arthroscopic Bankart group and 45% lower costs for the Latarjet group, although the difference was not clinically significant in the multivariate analysis (\$3 and \$15 in savings, respectively). It is possible that these savings were statistically significant but not clinically important in the multivariate analysis because of an association between higher facility volume and private ownership. Although previous orthopaedic studies have investigated how surgery center ownership affects procedure utilization and time efficiency in the OR, this is the first to show evidence of cost savings for outpatient procedures performed in privately owned ambulatory surgery centers.^[@bibr25-2325967120926465],[@bibr27-2325967120926465]^ This finding is consistent with other recent literature showing that physician-owned hospitals provided cost savings for patients undergoing posterior lumbar fusion.^[@bibr19-2325967120926465]^

The comparison of operative times showed an association between high facility volume and shorter operative time for arthroscopic Bankart repair. Just as high-volume facilities had lower costs, they also had shorter average operative times, again implying familiarity with the equipment and procedures when performed in larger numbers. This also indicates that there may be a learning curve for performing arthroscopic Bankart repair.

Surgeon-controllable factors offer the best opportunity to provide cost savings. Operative time was a significant cost driver across all 3 procedures, ranging from \$69 to \$147 per minute. It is important for surgeons to be cognizant of their time efficiency in the OR. Additionally, longer operative times have been found to be a risk factor for postoperative hospital admission, which itself was the largest cost driver in the arthroscopic Bankart and Latarjet groups.^[@bibr6-2325967120926465]^ The use of regional anesthesia over general anesthesia was also found to increase costs in the arthroscopic Bankart and Latarjet groups in the univariate analysis. It was also a cost driver for arthroscopic Bankart repair in multivariate regression. This contrasts with the results of Gonano et al,^[@bibr10-2325967120926465]^ who found that interscalene block was actually associated with decreased total anesthesia costs primarily because of a decrease in OR and postanesthesia care unit (PACU) time. Several studies have also found decreased hospitalization rates with the use of peripheral nerve blockade for orthopaedic procedures, which may offset its up-front cost by preventing unexpected postoperative admission in some patients.^[@bibr5-2325967120926465],[@bibr13-2325967120926465]^ Our multivariate results for arthroscopic Bankart repair controlled for the cost of postoperative admission and still found regional anesthesia added to the cost. A possible reason for this is that regional anesthesia may decrease time spent in the PACU, and this may not have been fully accounted for in our analysis because we did not have data on PACU time. Although providers should be cognizant of the additional up-front cost, they may still choose to use regional anesthesia for arthroscopic Bankart repair because of its previously shown utility in the prevention of readmission.^[@bibr5-2325967120926465],[@bibr13-2325967120926465]^

We also identified several patient demographic groups that experienced higher costs. Hispanic patients had higher costs in the arthroscopic Bankart group, even when controlling for all other significant factors. This has been noted in several previous studies of outpatient orthopaedic procedures.^[@bibr3-2325967120926465],[@bibr17-2325967120926465]^ Patients living in a ZIP code with a below-median income also had higher costs. It is unclear why Hispanic patients and patients with a lower income level had higher costs, but it is possible that social determinants of health or provider biases play a role. A previous study analyzed patients living in communities of low socioeconomic status and found a higher risk of developing postoperative complications, higher readmission rates, and higher costs of surgery.^[@bibr20-2325967120926465]^ The presence of at least 1 comorbidity was also an independent cost driver in the arthroscopic Bankart group likely because of the added medical complexity underlying patients with comorbidities. Other studies have also found that patients with more comorbidities have higher costs for orthopaedic procedures.^[@bibr14-2325967120926465],[@bibr22-2325967120926465]^

There are several limitations inherent in this study. We did not have data on longer-term outcomes, such as revision rates, so we were unable to adjust costs for the long-term quality of the surgical procedures. As we were using claims-based databases, there was a risk of misclassification or miscoding of data elements when they were collected. We also were using total charges as a proxy for the cost of surgery, and a further breakdown of charges was not available. Total charges may not be the same as the reimbursement that a provider receives or the true cost of a procedure. Billing practices may also vary across sites. We studied a large sample size from 6 states to mitigate the effects of any billing variations, and this methodology has been accepted in several previous orthopaedic publications.^[@bibr2-2325967120926465][@bibr3-2325967120926465]--[@bibr4-2325967120926465],[@bibr16-2325967120926465][@bibr17-2325967120926465]--[@bibr18-2325967120926465]^ Our selection of 6 states provided a geographically representative sample. However, there still may have been differences between these states and those not included in the study with regard to surgical and billing practices. Finally, the calculation of total charges did not account for postoperative care including physical therapy and out-of-work status. While these may have differed among the procedures, our goal was to identify surgery- and patient-specific factors associated with increased cost, and further studies may seek to identify these additional cost factors. Despite the limitations inherent in our data set, this study can better inform surgeons when counseling patients. The trends identified can also prove useful to surgeons looking for ways to achieve cost savings.

Conclusion {#section11-2325967120926465}
==========

This study identified a number of demographic and surgical variables that influence the cost of 3 methods of anterior shoulder stabilization. Postoperative admission to the hospital was the largest cost driver for arthroscopic Bankart repair and the Latarjet procedure. Low-volume surgical facilities were the largest cost driver for open Bankart repair. Privately owned and high-volume surgery centers both had lower costs when compared with hospital-owned and low-volume surgery centers. Longer operative times increased costs across all 3 procedures, and use of a nerve block increased costs in the arthroscopic Bankart and Latarjet groups. Surgeons may find these trends useful for reducing costs in their practices, particularly considering increasing trends toward bundled health care payments.
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